These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34789121)

  • 1. Prothymosin α and its C-Terminal Immunoreactive Decapeptide Show No Evidence of Acute Toxicity: A Preliminary
    Birmpilis AI; Vitsos P; Kostopoulos IV; Williams L; Ioannou K; Samara P; Karachaliou CE; Voutsas IF; Alyfanti E; Angelis N; Gavalas NG; Gkraikou T; Kappa N; Klagkou E; Klimentzou P; Nikou S; Papaioannou NE; Skopeliti M; Toukli D; Dimopoulos MA; Bamias A; Livaniou E; Kalbacher H; Tsitsilonis OE; Voelter W
    Curr Med Chem; 2022; 29(42):6463-6478. PubMed ID: 34789121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor Reactive T-Cell Responses Are Enhanced In Vivo by DAMP Prothymosin Alpha and Its C-Terminal Decapeptide.
    Birmpilis AI; Karachaliou CE; Samara P; Ioannou K; Selemenakis P; Kostopoulos IV; Kavrochorianou N; Kalbacher H; Livaniou E; Haralambous S; Kotsinas A; Farzaneh F; Trougakos IP; Voelter W; Dimopoulos MA; Bamias A; Tsitsilonis O
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31717548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothymosin α and a prothymosin α-derived peptide enhance T(H)1-type immune responses against defined HER-2/neu epitopes.
    Ioannou K; Derhovanessian E; Tsakiri E; Samara P; Kalbacher H; Voelter W; Trougakos IP; Pawelec G; Tsitsilonis OE
    BMC Immunol; 2013 Sep; 14():43. PubMed ID: 24053720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific in vitro binding of a new (99m)Tc-radiolabeled derivative of the C-terminal decapeptide of prothymosin alpha on human neutrophils.
    Karachaliou CE; Liolios C; Triantis C; Zikos C; Samara P; Tsitsilonis OE; Kalbacher H; Voelter W; Papadopoulos M; Pirmettis I; Livaniou E
    Int J Pharm; 2015; 486(1-2):1-12. PubMed ID: 25796124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker.
    Birmpilis AI; Paschalis A; Mourkakis A; Christodoulou P; Kostopoulos IV; Antimissari E; Terzoudi G; Georgakilas AG; Armpilia C; Papageorgis P; Kastritis E; Terpos E; Dimopoulos MA; Kalbacher H; Livaniou E; Christodoulou MI; Tsitsilonis OE
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-terminal decapeptide of prothymosin α is responsible for its stimulatory effect on the functions of human neutrophils in vitro.
    Samara P; Ioannou K; Neagu M; Arnogiannaki N; Ardavanis A; Voelter W; Tsitsilonis O
    Int Immunopharmacol; 2013 Jan; 15(1):50-7. PubMed ID: 23201434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID mice.
    Voutsas IF; Pistamaltzian N; Tsiatas ML; Skopeliti M; Katsila T; Mavrothalassiti I; Spyrou S; Dimopoulos MA; Tsitsilonis OE; Bamias A
    Eur J Cancer; 2013 May; 49(7):1706-14. PubMed ID: 23276721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications?
    Samara P; Ioannou K; Tsitsilonis OE
    Vitam Horm; 2016; 102():179-207. PubMed ID: 27450735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an ELISA for the quantification of the C-terminal decapeptide prothymosin α(100-109) in sera of mice infected with bacteria.
    Samara P; Kalbacher H; Ioannou K; Radu DL; Livaniou E; Promponas VJ; Voelter W; Tsitsilonis O
    J Immunol Methods; 2013 Sep; 395(1-2):54-62. PubMed ID: 23831611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunologically active site of prothymosin alpha is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients.
    Skopeliti M; Voutsas IF; Klimentzou P; Tsiatas ML; Beck A; Bamias A; Moraki M; Livaniou E; Neagu M; Voelter W; Tsitsilonis OE
    Cancer Immunol Immunother; 2006 Oct; 55(10):1247-57. PubMed ID: 16453152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo biodistribution and imaging studies with a
    Karachaliou CE; Triantis C; Liolios C; Palamaris L; Zikos C; Tsitsilonis OE; Kalbacher H; Voelter W; Loudos G; Papadopoulos M; Pirmettis I; Livaniou E
    Eur J Pharm Biopharm; 2017 Apr; 113():188-197. PubMed ID: 28087377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothymosin Alpha: An Alarmin and More..
    Samara P; Karachaliou CE; Ioannou K; Papaioannou NE; Voutsas IF; Zikos C; Pirmettis I; Papadopoulos M; Kalbacher H; Livaniou E; Tsitsilonis OE; Voelter W
    Curr Med Chem; 2017; 24(17):1747-1760. PubMed ID: 28521686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothymosin Alpha: A Novel Contributor to Estradiol Receptor Alpha-Mediated CD8
    Passos LSA; Jha PK; Becker-Greene D; Blaser MC; Romero D; Lupieri A; Sukhova GK; Libby P; Singh SA; Dutra WO; Aikawa M; Levine RA; Nunes MCP; Aikawa E
    Circulation; 2022 Feb; 145(7):531-548. PubMed ID: 35157519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy.
    Ioannou K; Samara P; Livaniou E; Derhovanessian E; Tsitsilonis OE
    Cancer Immunol Immunother; 2012 May; 61(5):599-614. PubMed ID: 22366887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothymosin-α Variants Elicit Anti-HIV-1 Response via TLR4 Dependent and Independent Pathways.
    Gusella GL; Teixeira A; Aberg J; Uversky VN; Mosoian A
    PLoS One; 2016; 11(6):e0156486. PubMed ID: 27310139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fragment of the alarmin prothymosin α as a novel biomarker in murine models of bacteria-induced sepsis.
    Samara P; Miriagou V; Zachariadis M; Mavrofrydi O; Promponas VJ; Dedos SG; Papazafiri P; Kalbacher H; Voelter W; Tsitsilonis O
    Oncotarget; 2017 Jul; 8(30):48635-48649. PubMed ID: 28611290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of mature Nα-terminal acetylated thymosin α 1 by cleavage of recombinant prothymosin α.
    Liu B; Gong X; Chang S; Sun P; Wu J
    ScientificWorldJournal; 2013; 2013():387282. PubMed ID: 24288480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothymosin alpha immunoactive carboxyl-terminal peptide TKKQKTDEDD stimulates lymphocyte reactions, induces dendritic cell maturation and adopts a beta-sheet conformation in a sequence-specific manner.
    Skopeliti M; Iconomidou VA; Derhovanessian E; Pawelec G; Voelter W; Kalbacher H; Hamodrakas SJ; Tsitsilonis OE
    Mol Immunol; 2009 Feb; 46(5):784-92. PubMed ID: 18976813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of SNARE Protein Interaction for Non-classical Release of DAMPs/Alarmins Proteins, Prothymosin Alpha and S100A13.
    Matsunaga H; Halder SK; Ueda H
    Cell Mol Neurobiol; 2021 Nov; 41(8):1817-1828. PubMed ID: 32856232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a specific IgY-based ELISA for prothymosin alpha, a bioactive polypeptide with diagnostic and therapeutic potential.
    Karachaliou CE; Kostopoulos IV; Vassilakopoulou V; Klimentzou P; Paravatou-Petsotas M; Voelter W; Kalbacher H; Zikos C; Tsitsilonis O; Livaniou E
    Heliyon; 2019 Oct; 5(10):e02616. PubMed ID: 31720448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.